摘要 It is an honor to be the guest editor of this special issue on Current Consensus and Controversy on Male Lower Urinary Tract Symptoms (LUTS)/Benign Prostatic Hyperplasia (BPH). As the title implies, one can write on a wide range of topics related to this urological problem that is common worldwide.
Abstract: It is an honor to be the guest editor of this special issue on Current Consensus and Controversy on Male Lower Urinary Tract Symptoms (LUTS)/Benign Prostatic Hyperplasia (BPH). As the title implies, one can write on a wide range of topics related to this urological problem that is common worldwide.
作者简介: Keong Tatt Foo,E-mail address:keongtatt@gmail.com
引用本文:
Keong Tatt Foo. Current consensus and controversies on male LUTS/BPH (part one)[J]. Asian Journal of Urology, 2017, 4(3): 137-137.
Keong Tatt Foo. Current consensus and controversies on male LUTS/BPH (part one). Asian Journal of Urology, 2017, 4(3): 137-137.
[1] Braeckman J, Denis L. Management of BPH then 2000 and now 2016-From BPH to BPO. Asian J Urol 2017;4:138-47. [2] Lim KB. Epidemiology of clinical benign prostatic hyperplasia. Asian J Urol 2017;4:148-51. [3] Foo KT. Pathophysiology of clinical benign prostatic hyperplasia. Asian J Urol 2017;4:152-7. [4] Taoka R, Kakehi Y. The influence of asymptomatic inflammatory prostatitis on the onset and progression of lower urinary tract symptoms in men with histologic benign prostatic hyperplasia. Asian J Urol 2017;4:158-63. [5] Ngai HY, Yuen KKS, Ng CM, Cheng CH, Chu SKP. Metabolic syndrome and benign prostatic hyperplasia:an update. Asian J Urol 2017;4:164-73. [6] Mehraban D. Clinical value of intravesical prostatic protrusion in the evaluation and management of prostatic and other lower urinary tract diseases. Asian J Urol 2017;4:174-80. [7] Vasanwala FF, Wong MYC, Ho HSS, Foo KT. Benign prostatic hyperplasia and male lower urinary symptoms:a guide for family physicians. Asian J Urol 2017;4:181-4. [8] Shum CF, Lau W, Teo CPC. Medical therapy for clinical benign prostatic hyperplasia:α1 Antagonists, 5α reductase inhibitors and their combination. Asian J Urol 2017;4:185-90. [9] Ng KK, Ng FC. The use of antimuscarinics, phosphodiesterase type V inhibitors and phytotherapy for lower urinary tract symptoms in men. Asian J Urol 2017;4:191-4. [10] Teo JS, Lee YM, Ho HSS. An update on transurethral surgery for benign prostatic obstruction. Asian J Urol 2017;4:195-8.
Christopher Hartman, Nikhil Gupta, David Leavitt, David Hoenig, Zeph Okeke, Arthur Smith. Advances in percutaneous stone surgery[J]. Asian Journal of Urology, 2015, 2(1): 26
-32
.
